Global Tumor Embolization Market Size and Forecast 2023-2032|Boston Scientific Corporation, Medtronic PLC, Terumo Corporation, Sirtex Medical Limited, Merit Medical Systems Inc

The Tumor Embolization Devices Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2011-2022) and extends its insights into a ten-year forecast period (2024-2033).

Learn More On The Tumor Embolization Devices Market:

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

According to The Business Research Company’s Tumor Embolization Devices Global Market Report 2024, The tumor embolization devices market size has grown rapidly in recent years. It will grow from $1.62 billion in 2023 to $1.82 billion in 2024 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to minimally invasive procedures, technological advancements, cancer incidence, aging population.

The tumor embolization devices market size is expected to see rapid growth in the next few years. It will grow to $2.83 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to personalized medicine, combination therapies, image-guided embolization, telemedicine and remote consultations. Major trends in the forecast period include innovations in embolic agents, transarterial chemoembolization (tace), embolization for palliative care, image-guided procedures.

The rise in the number of cancer cases across the globe is likely to contribute to the growth of the tumor embolization devices market during the forecast period. According to the American Cancer Society, there were about 1.9 million new cases and 608,570 cancer deaths in 2021 in the USA. The four most common types of cancers worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all new cancer cases. Therefore, the rise in the cancer incidence rate globally is anticipated to boost the demand for the tumor embolization market over the forthcoming years.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=3352&type=smp

The tumor embolization devices market covered in this report is segmented –

1) By Type: Radioembolic Agents; Non-radioactive Embolic Agents

2) By Application: Cancer Tumors; Noncancerous Tumors

3) By End User: Hospitals; Cancer Treatment Centers; Intensive Care Units; Surgical Centers

The tumor embolization devices market report table of contents includes:

1. Executive Summary

2. Tumor Embolization Devices Market Characteristics

3. Tumor Embolization Devices Market Trends And Strategies

4. Tumor Embolization Devices Market – Macro Economic Scenario

5. Global Tumor Embolization Devices Market Size and Growth